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Abstract: A series of symmetrical and unsymmetrical alkyl tren based tris-thiourea anion transporters
were synthesised and their anion binding and transport properties studied. Overall, increasing the
steric bulk of the substituents resulted in improved chloride binding and transport abilities. Including
a macrocycle in the scaffold enhanced the selectivity of chloride transport in the presence of fatty
acids, by reducing the undesired H+ flux facilitated by fatty acid flip-flop. This study demonstrates
the benefit of including enforced steric hindrance and encapsulation in the design of more selective
anion receptors.
Keywords: anion transport; thioureas; lipid bilayer
1. Introduction
Anion transporters that can restore chloride flux through apical epithelial cell membranes have
potential to function as ‘channel replacement therapies’ to ameliorate the symptoms of diseases,
such as cystic fibrosis (CF) [1–7]. CF is a channelopathy, where a genetic mutation to the cystic
fibrosis transmembrane conductance regulator (CFTR) protein results in a malfunctioning chloride
channel [8–10]. A reduced level of anion (Cl− and HCO3−) transport occurs, leading to a lower
level of osmosis. As a result, sticky mucous secretions occur which results in inflammation and
infections particularly in the lungs [11]. Synthetic chloride transporters have the potential to bypass
the faulty channel and restore activity by independently diffusing across the membrane as a chloride
complex. Our research group has recently focused on designing transporters that are selective for
chloride over proton transport [12], as dissipation of pH gradients in cells has been shown to trigger
apoptosis [13–15], and may disrupt the autophagic process [16,17]. Therefore, the development of
selective chloride transporters that do not facilitate H+/OH− transport is an attractive goal in the
development of putative channel replacement therapies.
Recently, we discovered that anionophores can act as functional mimics of uncoupling proteins,
and facilitate H+ transport via facilitated fatty acid transport [18]. Receptors can complex the negatively
charged fatty acid carboxylate head group and mediate its passage through the lipid bilayer membrane.
Decomplexation occurs, the free fatty acid protonates and diffuses back across the membrane, thus
resulting in proton transport. The rate determining step in the transport cycle is diffusion of the free
receptor, while fatty acid flip-flop provides an alternate pathway through the membrane for anion
transporters, which results in an increased rate of H+/Cl− symport. The increase in H+ transport via
this mechanism is undesirable in the case of chloride selective receptors for the treatment of CF.
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The challenge is to design receptors capable of chloride uniport that do not facilitate either the
transport of H+/OH− or fatty acid flip-flop. We have shown with a series of strapped calixpyrroles
that increasing the degree of encapsulation of a receptor results in a high degree of chloride selectivity,
which is not compromised in the presence of fatty acids [19]. To further investigate this phenomenon,
as well as the effects of steric hindrance and preorganisation of anionophores on Cl− > H+/OH−
selective transport, a series of receptors, shown in Figure 1, based on the tren scaffold were developed.
Previously, Wu et. al. [12] reported the transport selectivity of n-pentyl, 1, and t-pentyl, 4, substituted
tren compounds, and this inspired the study of two additional constitutional isomers, 2 and 3, with
varying ratios of n-pentyl and t-pentyl substituents. Receptor 5, with t-butyl groups, was created to
explore whether there is an optimum size for substituents. A macrocycle was incorporated into the
tren scaffold for receptor 6, and the macrocycle may encapsulate the binding site to a greater extent [20].
Furthermore, preorganisation of the thiourea anion binding groups could result in increased anion
binding affinities, which could potentially lead to improved anion transport abilities.
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performed to give 7, followed by transformation of the two free amines to isothiocyanate groups in 
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Figure 1. Structure of receptors 1–6.
In this paper, we report the synthesis of symmetrical, 5, and unsymmetrical tren based thiourea
anionophores 2, 3, and 6. The anion binding properties of the whole series of rec ptors were studied
with a range of biologically relevant anions. Elucidation of the transport mechanism was achieved
using cationophore coupled assays, and a full examination of the chloride transport activity as well as
investigations into the Cl− > H+/OH− transport selectivity were performed.
2. Results and Discussion
2.1. Synthesis
The synthesis of 1 and 4 was previously reported [12] and using the same method, receptor 5
was synthesised in an 82% yield. Compounds 2, 3, and 6 were synthesised via a multi-step procedure,
which is shown in Figure 2. In all cases, mono-Boc protection of tris-(2-aminoethyl)amine was
performed to give 7, followed by transformation of the two free amines to isothiocyanate groups
in 8. Intermediate 8 was reacted with either n-pentyl amine, t-pentyl amine, or di-aminoheptane to
obtain the Boc-protected product of receptors 2, 3, and 6, intermediates 9–11, respectively. From here,
Boc-deprotection and subsequent coupling with the appropriate alkyl thiourea gave receptors 2 and 6
in 55% and 7% yields. However, these conditions were repeatedly unsuccessful in the case of receptor
3, therefore, an alternate route was employed. Tris-(2-aminoethyl)amine was reacted directly with
t-pentyl isothiocyanate in a 1:2 molar ratio to favour formation of the di-substituted product. After
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separation of the desired di-t-pentyl mono-amine tren by column chromatography, coupling with the
n-pentyl thiourea gave receptor 3 in an 83% yield. Full synthetic details and characterisation can be
found in the Supplementary Material.
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Figure 2. Scheme of the synthetic procedure for unsymmetrical and macrocyclic tren-based
thiourea receptors.
2.2. Anion Binding Studies
The ability of receptors 1–6 to bind biologically relevant anions in solution was investigated using
1H NMR titrations in DMSO-d6/0.5% H2O, with the anion added as either the tetr butylammonium
(TBA) or tetraethylammonium (TEA) salt. Where possible, the change i the chemical shift of more
than one resonance was followed, allowing gl bal fitting of the titration data to a 1:1 bi ding model
using Bindfit [21]; summarised in Table 1.
Table 1. Stability constants (Ka) for the complexation of receptors 1–6 with chloride, bicarbonate, and
dihydrogen phosphate (as TBA salts for chloride and dihydrogen phosphate and TEA for bicarbonate)
in DMSO-d6/0.5% H2O at 298 K.
Receptor
Ka (M−1) for 1:1 Receptor:Anion Complex
Ka Cl− a Ka HCO3− b Ka H2PO4− b
1 346 5010 c n.d. d
2 770 e 5560 f n.d. g
3 1080 e 2460 f n.d. g
4 1530 1500 7460
5 1110 2670 2600
6 2170 b, e 4930 h n.d. g
All errors < 15%. a Host concentration 5 mM. b Host concentration 1 mM. c Fitted to 7.5 equiv. as peaks broadened
and merged at 10 equiv. d No association constant determined, peaks broaden up to 1 eq due to strong binding,
then peaks sharpen between 1–4 equiv. from formation of the 1:1 complex, above 4 equiv. peaks broaden signifying
the presence of the 1:2 complex. e Two resonances followed and fitted. f Three resonances followed and fitted. g No
association constant determined, peaks broaden up to 1 equiv., then peaks sharpen between above 1 equiv. h One
resonance followed and fitted.
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The chloride binding affinity increases for the more sterically hindered receptors through the
series. The strongest binding to chloride was observed for the macrocyclic receptor 6, presumably
due to a preorganisation effect. As expected, the overall binding affinity to bicarbonate was stronger
than chloride with the macrocycle, 6, again exhibiting the highest binding affinity. However, for
receptors 1–5, the opposite trend was evident, and the increased steric bulk of receptors resulted in
a decrease in binding affinity to the larger bicarbonate anion through the series. Peak broadening
occurred during titrations with dihydrogen phosphate and therefore association constants could not
be determined for receptors 1–3 and 6. Very high binding affinity was observed between receptors 4
and 5 with dihydrogen phosphate.
2.3. Anion Transport Studies
2.3.1. Transport Mechanism
Complementary cationophore coupled assays have been used to determine the transport
mechanism of several classes of receptors [22–24]. The assay uses naturally occurring cationophores,
valinomycin and monensin, that facilitate potassium transport by different mechanisms. Valinomycin
is an electrogenic transporter and this process involves the net flow of charge across a membrane [25].
Selective potassium transport facilitated by valinomycin can dissipate the membrane potential
produced by chloride uniport facilitated by electrogenic anion receptors, leading to an overall KCl
efflux. In contrast, monensin functions as an electroneutral transporter and during the transport
process, the charge is balanced by back transport of a species with the same charge [26]. Deprotonation
of a carboxylic acid group occurs upon metal complexation, allowing K+/H+ exchange, which couples
to the H+/Cl− symport (or functionally equivalent Cl−/OH− antiport) facilitated by an electroneutral
receptor, resulting in overall KCl efflux.
To set up the assay detailed in Figure 3, large unilamellar vesicles (LUVs, 200 nm)
composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, 200 nm diameter) were
prepared containing potassium chloride (KCl, 300 mM) internal solution, and suspended in
an external solution of potassium gluconate (K-Glu, 300 mM), both buffered to pH 7.2 with
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer (5 mm). As DMSO solutions,
cationophores were added at t = −30 s followed by receptors at t = 0 s, and the resulting chloride efflux
was monitored using a chloride ion selective electrode (ISE). At t = 300 s, the vesicles were lysed with
detergent to give a measurement corresponding to a 100% chloride efflux, allowing calibration of the
results. DMSO was tested as a control and no chloride efflux was detected, therefore the integrity of
the vesicles is not affected by the amount of DMSO used.
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Figure 3. Overview of the complementary cationophore coupled assay. POPC vesicles (grey) contain
an internal KCl (300 mM) solution and are suspended in an external K-Glu (300 mM) solution both
buffered to pH 7.2 with HEPES. KCl efflux monitored by a chloride ISE (navy) induced by valinomycin
(Vln, blue) facilitated electrogenic K+ transport coupled to compound (C, purple) mediated Cl− uniport
(right), and monensin (Mon, red) facilitated electroneutral K+/H+ exchange coupled to compound (C,
purple) mediated Cl−/H+ symport (left).
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Receptors 1–6 were tested in the cationophore coupled assay, and the results are shown in Figure 4.
In all cases, ~100% chloride efflux was achieved in the presence of valinomycin. Receptors 1–5
displayed a small degree (<20%) of chloride efflux when coupling to monensin. Due to inactivity at the
initial concentration (0.1 mol%, results in Supplementary Material), receptor 6 was tested at a higher
concentration (0.5 mol%). An increase in electroneutral H+/Cl− symport to ~60% was observed for
receptor 6 in the presence of monensin. The results indicated that receptors 1–6 function predominantly
as electrogenic chloride transporters, and macrocyclic receptor 6 is capable of some electroneutral
chloride transport at higher receptor concentrations.
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using a modified NMDG-Cl assay [12,27]. Three previously optimized conditions [18] were 
employed. Firstly, (a) in bovine serum albumin (BSA) (1 mol%) treated vesicles (BSA was used to 
sequester any fatty acids present in the vesicles giving a fatty acid free lipid bilayer). Secondly, (b) in 
the presence of gramicidin (Gra, 0.1 mol%) added to facilitate electrogenic H+ efflux, enabling the 
study of receptor mediated Cl- uniport. Finally, (c) in the presence of the naturally occurring fatty 
acid, oleic acid (OA, 2 mol%), which is found in cell membranes and can artificially enhance the 
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Figure 4. Results from the cationophore coupled assay. Chloride efflux facilitated by receptor (filled
purple), receptor coupled to valinomycin (0.1 mol%, filled blue), and receptor coupled to monensin
(0.1 mol%, filled red). The cationophore was added at t = −30 s, the receptor was added at t = 0 s, and
detergent was added at t = 300 s. DMSO (grey), valinomycin (empty blue), and monensin (empty red)
were tested as controls and each data point is the average of two repeats with the error bars showing
the standard deviation. (a) Receptor 1 (0.1 mol%). (b) Receptor 2 (0.1 mol%). (c) Receptor 3 (0.1 mol%).
(d) Receptor 4 (0.1 mol%). (e) Receptor 5 (0.1 mol%). (f) Receptor 6 (0.5 mol%).
2.3.2. Chloride Transport Selectivity
Quantification of the transport ability and Cl− > H+/OH− selectivity of receptors 1–6 was
achieved using a modified NMDG-Cl assay [12,27]. Three previously optimized conditions [18] were
employed. Firstly, (a) in bovine serum albumin (BSA) (1 mol%) treated vesicles (BSA was used to
sequester any fatty acids present in the vesicles giving a fatty acid free lipid bilayer). Secondly, (b) in
the presence of gramicidin (Gra, 0.1 mol%) added to facilitate electrogenic H+ efflux, enabling the
study of receptor mediated Cl− uniport. Finally, (c) in the presence of the naturally occurring fatty acid,
oleic acid (OA, 2 mol%), which is found in cell membranes and can artificially enhance the overall rate
of H+/Cl− symport. Anion transporters can accelerate the fatty acid flip-flop mechanism by taking on
the role of a flippase for fatty acid anions. Receptors bind to the anionic carboxylate head group and
mask the charge, allowing rapid passage of the head group through the lipid bilayer. The carboxylate
group can then protonate and diffuse back across the membrane and subsequently deprotonate,
effectively resulting in H+ transport. Dose response studies and subsequent Hill analysis [28] for the
three conditions detailed allowed the calculation of EC50 values to give the effective concentration of
transporter required to achieve 50% chloride efflux from the vesicles. The results are shown in Table 2.
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Table 2. EC50 values shown for the NMDG-Cl assay with receptors 1–6 in BSA treated vesicles, in the
presence of gramicidin (Gra) and in the presence of oleic acid (OA).
Receptor
EC50 (mol%) a
FGra e FOA f FOA/Gra
g
(a) BSA b (b) Gra c (c) OA d
1 0.236 0.0113 0.0214 21 11 1.9
2 0.218 0.00748 0.0195 29 11 2.6
3 0.175 0.00420 0.00834 42 21 1.9
4 0.164 0.00223 0.00970 74 17 4.3
5 0.295 0.00483 0.0121 61 24 2.5
6 1.900 0.0238 0.126 80 15 5.4
Values obtained are concentration dependent and can change with different assay conditions, e.g., EC50 values of
previously reported receptors 1 and 4 are lower due to the higher volume of DMSO solutions used [12,18]. a Values
reported in transporter to lipid molar ratio (mol %). b Measures Cl−/H+ symport (Cl−/OH− antiport) after vesicle
treatment with BSA (1 mol%). c Measures total Cl−/H+ symport (Cl−/OH− antiport), rate limiting H+ transport is
facilitated by Gra (0.1 mol%). d Measures Cl−/H+ symport (Cl−/OH− antiport), with H+ transport facilitated by
the fatty acid flip-flop of OA (2 mol%). e Factor of enhancement in the Cl− uniport in the presence of Gra, FGra is
calculated by dividing the EC50 (BSA) by the EC50 (Gra). FGra > 1 indicates Cl− transport enhancement. f Factor of
enhancement in the overall rate of Cl−/H+ cotransport in the presence of OA, FOA is calculated by dividing the
EC50 by the EC50 (OA). FOA > 1 indicates the receptor can assist the flip-flop of OA−, increasing pH dissipation. g
Factor of chloride transport selectivity retention in the presence of oleic acid, FGra/OA is calculated by dividing the
EC50 (OA) by the EC50 (Gra). FGra/OA > 1 indicates Cl− selectivity retention.
POPC LUVs (200 nm) were loaded with N-methyl-D-glucamine chloride (NMDG-Cl, 100 mM)
and 8-hydroxypyrene-1, 3, 6-trisulfonic acid (HPTS, a pH sensitive dye, 1 mM), and suspended in an
external solution of NMDG-Cl. All solutions were buffered to pH 7 with HEPES (10 mM). Receptors
were added as a DMSO solution at t = −15 s, and transport was initiated by the addition of an
NMDG (0.5 M) base pulse at t = 0 s, which increased the external pH to 8. The fluorescence ratio of
8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS) (basic form, λex = 460 nm, λem = 510 nm,
divided by the acidic form, λex = 403 nm, λem = 510 nm) was monitored as the pH gradient across the
membrane was dissipated by either: (a) Receptor mediated H+/Cl− symport (or OH−/Cl− exchange),
(b) a combination of receptor mediated Cl− uniport coupled to H+ efflux facilitated by Gra, and
receptor mediated H+/Cl− symport, or (c) a combination of receptor mediated Cl− symport coupled
to H+ efflux facilitated by fatty acid flip-flop, and receptor mediated H+/Cl− symport. The assay
conditions and transport pathways are shown in Figure 5.
Receptors 1–6 display poor H+/Cl− symport abilities in BSA treated vesicles in the NMDG-Cl
assay (Table 2). The low activity was expected, as the cationophore coupled assay showed these
compounds predominantly function as electrogenic chloride transporters rather than electroneutral
H+/Cl− co-transporters. However, mirroring the trend in the chloride binding affinities, the EC50
values for receptors 1–4 decreased, indicating better transport abilities, as the encapsulation increases
from additional t-pentyl substitution. Receptor 4 is the best transporter of this series with the lowest
EC50 of 0.164 mol% in the BSA treated vesicles. t-Butyl substitution in receptor 5 results in the second
worst transport ability in this series, suggesting that the more lipophilic pentyl substitution is favoured
over butyl substitution. Although it displays the strongest chloride binding affinity, macrocyclic
receptor 6 has the highest EC50 of the series. The poorer chloride transport is potentially due to the
more rigid structure of the macrocycle, reducing the deliverability, and hindering passage of the free
receptor as well as the receptor:chloride complex across the lipid bilayer.
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it through the membrane as the negatively charged complex. The anion dissociates on the exterior of 
the membrane. The neutral receptor binds to a negatively charged deprotonated fatty acid (COO-, 
orange) and moves across the membrane as the negatively charged complex. Fatty acids can 
translocate across the membrane when protonated (H+, blue) to complete the cycle. 
Including the proton channel, Gra, in the NMDG-Cl assay accelerates H+ efflux across the 
membrane. Therefore, the rate-limiting H+ transport step for electrogenic receptors 1–6 is removed, 
and the rate of chloride uniport is increased. A decrease in EC50 values by over one order of 
magnitude in all cases indicated an increase in chloride transport. A factor of enhancement in chloride 
transport (FGra) was then quantified, by dividing (a) EC50 (BSA) by (b) EC50 (Gra). Values > 1 demonstrate 
an enhancement of the chloride transport, and the results are shown in Table 2. A bar chart is also 
included for clarity in Figure 6. Calculated FGra values showed impressive enhancement in chloride 
transport for all receptors. The most encapsulating receptors, 4–6, displayed the highest FGra values, 
and macrocyclic receptor 6 showed the largest enhancement in chloride transport of the series. The 
same trend was repeated for receptors 1–4. Increasing encapsulation from additional t-pentyl 
substituents resulted in higher FGra values, corresponding to increased chloride uniport. 
Figure 5. Top: Overview of the NMDG-Cl assay. POPC vesicles (grey) contain an internal NMDG-Cl
(100 mM) and HPTS (1 mM) solution and are suspended in an external NMDG-Cl (100 mM) solution
both buffered to pH 7.2 with HEPES (10 mM). HCl efflux, monitored by pH sensitive HPTS, induced
by (a) compound (C, purple) mediated Cl−/H+ symport, (b) gramicidin (Gra, green) facilitated
electrogenic H+ efflux coupled to compound (C, purple) mediated Cl− uniport, and (b) oleic acid (OA,
orange) flip-flop facilitated H+ transport coupled to compound (C, purple) mediated Cl−/H+ symport.
Bottom: (a) Compound mediated Cl−/H+ symport via receptor deprotonation. The neutral receptor (T,
purple) binds an anion (Cl−, green). The negatively charged complex moves across the membrane, and
the anion dissociates. The receptor is deprotonated (H+, blue), and the negatively charged receptor
moves across the embrane. The receptor is protonated to complete the cycle. (b) Compound mediated
Cl− uniport. The neutral receptor (T, purple) binds an anion (Cl−, green). The negatively charged
complex moves across the membrane, and the anion dissociates. Gramicidin (Gra, green) facilitates
electrogenic H+ efflux to balance the charge gradient build up. The neutral receptor diffuses back
across t e e brane to complete the cycle. (c) Compound mediated Cl−/ sy port co le to fatty
aci fli -fl at ay. he neutral receptor (T, purple) binds an anion (Cl−, green) and transports it
throug the embrane as th negatively charged complex. The anion dissociates on th exterior of the
membrane. The ne tral t binds to a negatively charged eprotonated fatty acid (COO−, orange)
and moves across the membrane as the negatively charg d complex. Fatty acids c n translocate across
the membrane when protonated (H+, blue) to complet the cycle.
Including the proton channel, Gra, in the NMDG-Cl assay accelerates H+ efflux across the
membran . Therefore, th rate-limiting H+ transport step for electrogenic receptors 1–6 is removed,
and the rate of chloride uniport is i s . A decrease in EC50 values by over one ord r f magnitude
in all cases indicate an increase in chloride transport. A factor of enhancement in chloride t ansport
(FGra) was then quantified, by divi ing (a) EC50 (BSA) by (b) EC50 (Gra). Values > 1 demonstrate an
enhancement of the c l i t, and the results are shown i Table 2. A bar chart is also included
for clarity in Figure 6. Calculated FGra values showed impressive enhanc ment in chloride transport for
all eceptors. The mo t encapsulati g receptors, 4–6, displayed the high st FGra values, and macrocyclic
receptor 6 showed the largest enhancement in chloride transp t of the eries. The sam trend was
rep ated for receptors 1–4. Incr asing encapsulation from additional t-pentyl substituents r sulted in
higher FGra values, corresponding to increa ed chloride uniport.
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contribute to the naturally occurring fatty acid transmembrane proton shuttling pathway, by 
assisting the flip-flop of the negatively charged fatty acid head group. The pathway is depicted in 
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of H+/Cl- transport in the presence of OA to be calculated. The results shown in Table 2 and Figure 6, 
give FOA values > 1 for all receptors, indicating that the overall rate of H+/Cl- symport is increased due 
to receptor coupled fatty acid flip-flop. Enhancement factors are greater in the presence of Gra 
compared to OA. Therefore, receptors 1–6 preferentially facilitate chloride uniport compared to 
H+/Cl− symport, reinforcing the electrogenic transport mechanism shown by receptors 1–6 in the 
cationophore coupled assay.  
In the presence of OA, chloride uniport is often diminished, because receptors can display some 
affinity towards the fatty acid headgroup [18]. As free fatty acids are abundant in cell membranes, 
reducing affinity for fatty acid headgroups is an important consideration in the development of 
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can be calculated. Dividing (c) EC50 (OA) by (b) EC50 (Gra) gives FOA/Gra values, which can be found in 
Table 2. Values > 1 indicate a retention in chloride selective transport in the presence of OA. FOA/Gra 
values of ~2 were obtained for receptors 1–3 and 5, indicating a slight amount of chloride selective 
transport retention. Macrocyclic receptor 6 retained the highest degree of chloride selective transport 
in the presence of OA, FOA/Gra = 5.4, with the most encapsulating receptor 4 also retaining chloride 
selective transport, FOA/Gra = 4.3. The results demonstrate that it is advantageous to include enforced 
steric hindrance and encapsulation in the design of anion receptors to reduce affinity towards the 
fatty acid headgroup and retain chloride selective transport. 
3. Conclusions 
We have shown that increasing the steric hindrance of simple tren based receptors results in an 
increase in binding affinity towards chloride. However, the reduced structural freedom of these 
receptors results in a decrease in binding affinity towards the bicarbonate anion. From the 
Figure 6. Chloride transport enhancement results. In the presence of Gra, a factor of chloride
transport enhanc me t, FGra, (green) is calculated by dividing the EC50 (BSA) by the EC50 (Gra). Factor
of enhanc ment in the overall rate of Cl−/H+ cotransport in the presence of OA, FOA (or nge), is
calculat d by dividing the EC50 by the EC50 (OA). Values over th threshold (>1) indicat an increase in
the rate of chloride transport in the conditions described.
The addition of OA to the NMDG-Cl assay allowed an evaluation of the receptors’ ability to
contribute to the aturally ccurring fatty acid transmembrane proton shuttling pathway, by assisting
the flip-flop of the egatively ha ged fatty acid head group. The pathway is depicted in Figure 4.
Dividi (a) EC50 (BSA) by (c) EC50 (OA) allowed a factor of enhancement (FOA) in the overall rate of
H+/Cl− transport in the presence of OA to be calculated. The r sults show in Table 2 and Figu e 6,
give FOA v lues > 1 for all c ptors, indicating that th overall rate of H+/Cl− symport is increased
due to receptor coupled fatty acid flip-flop. Enhancement f ctors are greater in the presence of
Gra compared to OA. Therefore, receptors 1–6 pr ferentially facilitate chlo ide unipo t compared to
H+/Cl− symport, reinforcing the electrogenic transport mechanism s wn by receptors 1–6 in the
cationophore coupled assay.
In the presence of OA, chloride uniport is often diminished, because receptors can display some
affinity towards th fatty acid headgroup [18]. As free fatty acids are abundant in cell membranes,
reducing affinity for fatty acid headgroups is an impor ant onsid r tio in he development of
anionophores for the po ential treatment of CF. Theref re, an assessment of the ability of rec ptors
1–6 to retain chl ide selective transport in the presenc f OA wa calcula ed. Assuming the chloride
unip rt achieved in the presence of Gra (i.e., EC50 (Gra)) c rresponds to the chloride selective transport
by receptors 1–6, a factor of the chloride transport selectivity retention in the presenc of OA (FOA/Gra)
can be calculated. Dividing (c) EC50 (OA) by (b) EC50 (Gra) g ves FOA/Gra valu s, which can be found in
T ble 2. Val es > 1 ind cate a retention in chloride selective transpo t in th presence of OA. FOA/Gra
v lu s of ~2 were obta ned fo receptors 1–3 an 5, indicating a light amount of chloride selective
tr nsport retention. M crocyclic receptor 6 ret ined the highest degree of chloride selective transport
in the p es nce of OA, FOA/Gra = 5.4, with the most encapsula ing ceptor 4 also r taining chloride
selective tra sport, FOA/Gra = 4.3. The results demonstrate that t is advantageous to include enf rced
teric hindr ce and encapsulation in the design of anion receptor to reduce affinity towards the fatty
acid headg oup and r tain chloride selective transport.
3. Conclusions
We have shown that increasing the steric hindrance of simple tren based receptors results
in an increase in binding affinity towards chloride. However, the reduced structural freedom of
these receptors results in a decrease in binding affinity towards the bicarbonate anion. From the
cationophore coupled assay, it was evident that this series of tren-based tris-thiourea receptors function
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predominantly as electrogenic chloride transporters. The H+/Cl− symport activity of this series was
poor as to be expected, but chloride uniport in the presence of the proton channel, Gra, showed high
activity. Enhancement of chloride transport in the presence of Gra was impressive over the whole
series, however, all receptors were able to facilitate the undesirable fatty acid flip-flop proton transport
pathway at different degrees. This unwanted effect was less apparent for the more sterically hindered
receptors, 4 and 6, demonstrating the benefit of encapsulating receptors. Overall, this study shows
that an elaborated receptor design is crucial to minimise H+/OH− transport and to obtain chloride
selective transporters.
Supplementary Materials: Synthetic procedures and compound characterizations, methodology and results for
anion binding experiments, and methodology and results of anion transport experiments are available online at
http://www.mdpi.com/1420-3049/24/7/1278/s1. Figures S1–S104.
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